MDA-MB-231 LM2 (herein referred to as LM2) is a derivative of MDA-MB-231 cells that was selected for its ability to metastasize to lung tissue in vivo. We investigated cellular properties of LM2 including actin cytoskeleton organization, motility and signaling pathways that drive the expression of genes associated with the lung metastasis signature. Parental cells exhibit well-developed stress fibers, whereas LM2 had poorly organized stress fibers. LM2 exhibited higher levels of K-Ras protein and corresponding higher levels of phosphorylated ERK compared with parental cells. The Ras-ERK pathway was responsible for the disruption of stress fibers because inhibition of MEK with UO126 or small interfering RNA (siRNA) against K-Ras or ERK1/2 resulted in restoration of stress fibers and focal adhesions. We observed that the K-Ras-ERK pathway is important for the expression of genes associated with the lung metastasis signature. Paradoxically, inhibition of the Ras-ERK pathway did not result in inhibition of cell motility but was accompanied by activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of both ERK and PI3K pathways was required to inhibit motility of LM2 cells. These results suggest that both ERK and PI3K pathways drive motile functions of metastatic LM2 cells and genes associated with the lung metastasis signature.
INTRODUCTION
Cancer invasion and metastasis occur during the evolution of a primary tumor, where cells gain the ability to invade and metastasize, resulting in life-threatening disease. The process of tumor cell metastasis involves multiple steps including intravasation, extravasation and re-colonization. At the cellular level, metastasis involves motility, invasiveness (matrix degradation), survival signaling, cell proliferation and angiogenesis. Elucidating the genes and signaling pathways that mediate metastasis is a critical goal in the development of therapies targeting metastatic disease.
Oncogenic transformation is characterized not only by deregulated growth control but also by pronounced morphological changes resulting from alterations in the organization of the actin cytoskeleton and adhesive interactions. Cancer invasion involves signals that control cytoskeleton dynamics and cell-cell and cell-matrix interactions. Oncogene-mediated disruption of stress fibers and associated adhesive structures (focal adhesions) are known to have a critical role in pathways that increase motility and invasiveness of tumor cells, thereby facilitating metastasis. Changes in the organization of actin filaments are highly correlated with anchorage-independent growth, tumorigenicity and invasion, suggesting a fundamental role for actin fibers in cell growth control. 1, 2 Alterations in actin filament organization are associated with changes in the expression of various cytoskeleton proteins, [1] [2] [3] [4] [5] [6] as well as regulatory proteins including kinases, 7, 8 and activity of small GTPases of the Ras superfamily by several oncogenic signaling pathways. 9, 10 Oncogenic Ras has been shown to markedly affect actin organization, assembly of focal contacts and the formation of adherens junctions and tight junctions. [11] [12] [13] One of the best-characterized Ras effectors is the Raf/MEK/ERK pathway that exerts profound effects on actin cytoskeleton organization and adhesive structures. For example, the Ras-ERK pathway targets specific components of the actin cytoskeleton, leading to increased motility and invasiveness of Ras-transformed cells. We and others have demonstrated that part of the mechanism whereby oncogenic Ras alters cytoskeleton dynamics is by downregulating the RhoA/ROCK pathway by uncoupling Rho from stress fiber formation. 7, 10, 12, 14, 15 We still lack a complete understanding of how the Ras-ERK pathway effects contribute to properties of metastatic cells, including actin filament assembly and motility. Although the RhoA/ROCK pathway is one target, other factors are likely to be involved in mediating metastatic spread.
MDA-MB-231 LM2 (herein referred to as LM2) is a derivative of MDA-MB-231 cells (herein referred to as parental) that was selected for its ability to metastasize to lung tissue in vivo. 16 On the basis of microarray and functional genomics, a number of genes have been identified that are involved in the ability of these cells to form lung metastasis, the so-called lung metastasis signature. 16 These genes comprise a diverse set of functions including growth factors and cytokines, matrix metalloproteinases, cell adhesion molecules, receptors, transcription factors and regulators, cytoskeleton proteins and extracellular proteins. Functional genomics demonstrated that these genes have a role in the ability of cells to metastasize to the lung because silencing their expression in highly metastatic cells or overexpressing them in poorly metastatic cells resulted in decreased or increased lung metastasis, respectively.
Although studies of LM2 have identified a lung metastasis signature, comprising genes that are involved in the ability of cells to form lung metastasis, not much is known about the actin cytoskeleton and motile and invasive properties of LM2 cells, or which signaling pathways drive the expression of genes associated with the lung metastasis signature. To determine whether there are differences in the cytoskeleton and invasive properties of parental and LM2 cells at the cellular level, we undertook a systematic study of their properties. Parental cells exhibit well-developed stress fibers, whereas LM2 had poorly organized stress fibers. LM2 exhibited higher levels of expression of K-Ras protein, which appears to be responsible for the higher levels of phosphorylated ERK compared with parental cells, which was responsible for disruption of stress fibers and focal adhesions. Interestingly, inhibition of MEK or small interfering RNA (siRNA) against K-Ras or ERK1/2 resulted in restoration of stress fibers and focal adhesions but did not inhibit cell motility. Paradoxically, inhibition of the Ras-ERK pathway was accompanied by activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of both ERK and PI3K pathways were required to inhibit motility of LM2 cells. Finally, we observed that the K-Ras-ERK pathway is important for expression of genes associated with the lung metastasis signature. These results suggest that both ERK and PI3K pathways drive motile functions of metastatic LM2 cells and genes associated with the lung metastasis signature.
RESULTS
LM2 exhibits disruption of the actin cytoskeleton and enhanced motility To determine whether there are differences in the organization of the cytoskeleton and invasive properties of parental and LM2 cells at the cellular level, we undertook a systematic study of their properties. Whereas parental MDA-MB-231 cells exhibit welldeveloped stress fibers and a well-spread morphology, LM2 had poorly organized stress fibers and were spindle shaped ( Figure 1a ). LM2 cells also exhibit disrupted focal contacts. Immunofluorescence labeling with anti-vinculin antibodies showed that parental MDA-MB-231 cells contained well-developed focal contacts, whereas vinculin-stained LM2 cells exhibited a diffuse cytoplasmic pattern (Figure 1a) . A western blot analysis showed that the level of expression of vinculin was not affected in LM2 cells (data not shown). In wound-healing assays, LM2 cells exhibit higher rates of migration than the parental cells (Figure 1b ). In addition, LM2 cells exhibit strong invasive properties in vitro. We performed the Boyden chamber migration assay between the two cell lines. LM2 cells efficiently migrate through both naked PET (polyethylene terephthalate) membrane and membrane coated with a three-dimensional Matrigel matrix, respectively (Figures 1c and d) . These results show that, compared with parental MDA-MB-231 cells, LM2 cells exhibit disruption of the actin cytoskeleton and higher motile function and invasive behavior.
The K-Ras-ERK pathway is elevated in LM2 The results above suggest that LM2 could have a more active Ras-ERK pathway compared with parental cells, thereby inducing the observed morphological changes in actin filament organization in LM2. We next examined the levels of Ras effectors and whether LM2 exhibited higher levels of phosphorylated ERK compared with parental MDA-MB-231 cells. As shown in Figure 2a , LM2 exhibited higher levels of phosphorylated MEK and phosphorylated ERK compared with parental cells. Furthermore, we observed that LM2 cells contain elevated levels of K-Ras (Figure 2a ). In addition, we also examined the levels of various actin filamentassociated cytoskeleton proteins implicated in transformation (Figure 2b ). LM2 has less actin filament-associated proteins such as tropomyosins, phosphorylated regulatory light chain, RhoA and myosin light-chain kinase, which are known to be necessary components of actin filament structures. 9, 17, 18 We also noted that LM2 has a higher level of Fra-1 (Figure 2b ), which is reported to have an inhibitory role in stress fiber formation and integrin b1 function. 12, 19 As we found that LM2 has an elevated level of K-Ras, we determined whether knockdown of K-Ras reduces ERK phosphorylation, as well as upregulation of actin filament-associated proteins. Knockdown of K-Ras resulted in the downregulation of ERK phosphorylation (Figure 2c ). Moreover, silencing K-Ras with siRNA also resulted in increased expression level of actin filamentassociated proteins, including myosin light-chain kinase and tropomyosin, as well as increased levels of myosin light-chain phosphorylation (Figure 2c ). In addition, depletion of K-Ras in LM2 resulted in the formation of stress fibers (Figure 2d ). Ectopic expression of the active form of K-Ras induces disruption of stress fiber formation in parental cells, which was reversed by treatment with UO126 ( Figure 2e ). These results suggest that increased activation of the Ras-ERK pathway is responsible for differences in parental and LM2 cells.
Activation of the Ras-ERK pathway disrupts the actin cytoskeleton and focal adhesion in LM2 We next determined which signaling pathway is responsible for the disruption of the actin cytoskeleton. Previous studies from our and other laboratories have established a critical role for the Ras-ERK pathway in disruption of stress fibers and focal adhesions. 7, 10, 12, 14, 15 Therefore, we hypothesize that the phenotype of LM2 showing loss of stress fibers and focal adhesions may be driven by the Ras-ERK pathway. To determine whether the Ras-ERK pathway was responsible for the observed loss of stress fibers and focal contacts, LM2 cells were treated with 25 mM of the MEK inhibitor UO126. Stress fibers are noticeably absent in LM2, and following treatment with UO126 the actin organization changed from patches at the ends of spindle-shaped cells to cortical fibers surrounding cells after 5-10 h. After 24 h of UO126 treatment, actin filaments were organized into stress fibers, and by 48 h the stress fibers were extending throughout the entire cell body, thus resembling stress fiber organization of parental MDA-MB-231 cells (Figure 3a ). Stress fibers were also formed following treatment of LM2 cells with 10 and 20 mM UO126 (Supplementary Data Figure 1 ). Furthermore, depletion of ERK1/2 in LM2 with siRNA resulted in the formation of stress fibers (Supplementary Data Figure 2 ).
LM2 also exhibit disrupted focal contacts. Immunofluorescence labeling with anti-vinculin or anti-paxillin showed that LM2 cells had poorly developed focal contacts (Figure 3b ). Western blot analysis showed that the level of expression of vinculin and paxillin was not affected in LM2 compared with parental MDA-MB-231 cells (data not shown). Treatment of LM2 cells with 25 mM UO126 for 48 h led to the assembly of vinculin-and paxillin-containing focal contacts (Figure 3b ). These focal contacts were almost indistinguishable from those of parental MDA-MB-231 cells. This result suggests that constitutive activation of MEK prevents the assembly of focal contacts in LM2 cells and that inhibition of MEK is sufficient to reverse this effect.
We next tested whether treatment of LM2 cells with the MEK inhibitor UO126 would also effect the expression of several actin filament-associated proteins, which are suppressed in LM2. Treatment with UO126 induces marked expression level of actin filament-associated proteins including tropomyosin, myosin light-chain kinase and myosin light chain (Figure 3c ), similar to the effects of siRNA treatment against K-Ras (Figure 2c ). In addition, the level of Fra-1 is downregulated by inhibition of the Ras-ERK pathway either by UO126 treatment (Figure 3c ) or by knockdown of K-Ras in LM2 (Figure 2c ). Taken together, these results demonstrate that the Ras-ERK pathway has a pivotal role in the regulation of actin cytoskeleton organization in LM2 cells. We have also extended these studies to MDA231-BrM2 cells, which are a derivative of parental MDA-MB-231 cells that exhibit a preference for metastasis to the brain. 19 In agreement with our data regarding LM2 cells, we found that MDA231-BrM2 cells have poorly developed stress fibers, but upon treatment with UO126 they result in well-developed stress fibers, and increase in AKT phosphorylation (Supplementary Data Figure 3 ).
The Ras-ERK pathway drives expression of lung metastasis signature genes Although studies of LM2 have identified a lung metastasis signature, comprising genes that are involved in the ability of cells to form lung metastasis, not much is known about the signaling pathways that drive their expression. It is interesting to note that LM2 had a higher level of K-Ras and phosphorylated ERK compared with parental MDA-MB-231 cells (Figure 2a ). This led us to examine whether the Ras-ERK pathway drives the expression of genes associated with the metastatic signature in LM2 cells. We confirmed that the LM2 used in our present studies had higher expression level of lung metastasis signatures compared with parental cells, which is consistent with previous reports. 16 Reverse transcription-polymerase chain reaction (RT-PCR) results demonstrate that LM2 exhibits higher amounts of message level of genes associated with the lung metastasis signature, including MMP1, ANGPTL4, CXCL1, EREG, TNC (Tensacin-C) and PTGS2 (COX-2) (Figure 4a ). We next examined whether knockdown of K-Ras or treatment of UO126 reduces lung metastasis signature genes in LM2. Knockdown of K-Ras reduces the expression level of certain lung metastasis signature genes such as MMP1, PTGS2 and TNC (Figure 4b) . Furthermore, pharmacological inhibition of MEK by UO126 treatment dramatically reduces expression of lung metastasis signature genes (Figure 4c ). It is noteworthy that although LM2 has elevated protein level of K-Ras (Figure 2a) we could not detect significant differences in the level of mRNA for K-Ras between LM2 and parental MDA-MB-231 cells (Figure 4a ). In addition, K-Ras was not detected as lung metastasis signatures in the original description of LM2 using microarray analysis. 16 The elevated levels of K-Ras are likely due to a post-transcriptional mechanism. Collectively, these data demonstrate that the Ras-ERK pathway is required for the expression of genes associated with the lung metastasis signature, which are components necessary to colonize lung properly. 20, 21 Inhibition of the Ras-ERK pathway is not sufficient to inhibit cell motility of LM2 Because the Ras-ERK pathway was responsible for the loss of stress fibers and expression of genes associated with the lung metastasis signature, we asked whether the Ras-ERK pathway was responsible for the higher motility of LM2 compared with parental MDA-MB-231 cells. Initially, we expected that inhibition of the Ras-ERK pathway would suppress wound healing motility due to an elevated Ras-ERK pathway in LM2 (Figure 2a) . However, pretreatment of LM2 cells with the MEK inhibitor UO126 for 48 h did not significantly reduce the rate of wound healing motility of LM2 (Figure 5a ). We also performed the Boyden chamber migration assay. Similarly, treatment with UO126 did not significantly reduce migration in a Boyden chamber assay (Figure 5b) . We examined the effects of silencing the expression of K-Ras using siRNA on motility. Knockdown of K-Ras did not significantly affect wound healing motility of LM2 (Figure 5c ), in agreement with the pharmacological studies. Thus, although the Ras-ERK pathway was responsible for disruption of stress fibers and focal adhesions in LM2, inhibition of this pathway was not sufficient to inhibit cell motility.
Inhibition of the Ras-ERK pathway results in activation of the PI3K-AKT pathway, which contributes to cell motility We were surprised that inhibition of the Ras-ERK pathway did not result in reduced motility of LM2 cells. In addition to ERK, the PI3K pathway is also implicated in cell motility. 18, 22, 23 A number of studies have reported that, in some instances, inhibition of the Ras-ERK pathway will result in the activation of PI3K/AKT pathway. [24] [25] [26] We first determined whether inhibition of the Ras-ERK pathway in LM2 would result in the activation of the PI3K-AKT pathway. Accordingly, we tested whether treatment of LM2 cells with the MEK inhibitor UO126 or siRNA knockdown of K-Ras would affect the PI3K/AKT pathway. Either treatment with UO126 or silencing K-Ras resulted in the activation of the PI3K/AKT pathway (Figures 6a and b) . This led us to hypothesize that activation of the PI3K-AKT pathway contributes to motility in LM2 following inhibition of the Ras-ERK pathway. To determine whether activation of the PI3K pathway is involved in cell motility in LM2, we tested the effects of different combination treatments with UO126 and LY2940029. Treatment of LM2 cells with the PI3K inhibitor LY2940029 did not significantly reduce the motility of LM2 cells. Surprisingly, combinational treatment of LY2940029 and UO126 significantly reduced wound healing motility (Figure 6d ). These data demonstrate that activation of the PI3K/AKT pathway drives the motility of LM2 when the Ras-ERK pathway is downregulated.
DISCUSSION
The LM2 model is a derivative of MDA-MB-231 cells that was shown to have a preference in forming lung metastasis. 16 In this paper, we demonstrate that the Ras-ERK pathway disrupts stress fiber and focal adhesion formation in LM2 cells and thereby has a role in actin cytoskeleton dynamics. We show that the Ras-ERK pathway drives the expression of genes associated with the lung metastasis signature. We also demonstrate that inhibition of the Ras-ERK pathway results in the activation of PI3K signaling pathways, which promotes motility.
Ras-ERK pathway and stress fiber and focal adhesion formation Although parental MDA-MB-231 cells exhibit well-developed stress fibers and a well-spread morphology, LM2 had poorly organized stress fibers and focal adhesions. This prompted us to examine the molecular basis for the differences between these cells. We detected higher levels of K-Ras protein in LM2 compared with parental cells, which is responsible for the enhanced ERK activation. At this time, it is not clear how the levels of Ras protein are elevated in LM2. We did not detect differences between parental and LM2 cells in the levels of mRNA for K-Ras by RT-PCR. Thus, the enhanced Ras-ERK pathway is likely regulated by a posttranscriptional mechanism. Previous studies in various cell systems have demonstrated that the Ras-ERK pathway can lead to disruption of stress fibers and focal adhesion formation. 7, 10, 12, 14, 15 Stress fiber formation is dependent on actomyosin contractility regulated by several kinases that are related to phosphorylation of myosin regulatory light chain 2 and cofilin. Activation of RhoA is a well-established regulator of stress fiber and focal adhesion formation via phosphorylation of cofilin and myosin light chain 2, respectively. The main mechanism of the Ras-ERK pathway that disrupts stress fiber formation is by uncoupling Rho/ROCK activation from stress fiber formation. For example, active ERK reduces the activity of ROCK via post-transcriptional regulation 7 or cytoplasmic distribution of p21 cip1, which is capable of binding with ROCK. 10 In addition, RhoA activity could also be inhibited by ERK via regulation of cytoplasmic distribution of p27 kip1 27, 28 or Fra-1 expression. 11, 15, 29, 30 In agreement with these studies, we observed that LM2 exhibits lower levels of phosphorylated myosin light chain compared with parental MDA-MB-231 cells. Upon inhibition of the Ras-ERK following treatment with the MEK inhibitor UO126 or siRNA knockdown of K-Ras, we observed restoration of stress fibers and focal adhesions and increased phosphorylation levels of myosin light chain. Our results demonstrate that in LM2 cells organization of the actin-based cytoskeleton is mainly under the control of the Ras-ERK pathway.
The Ras-ERK pathway drives the expression of genes associated with the lung metastasis signature LM2 was originally derived from the human breast cancer cell line MDA-MB-231 in a mouse xenograft model to select cell populations that are highly metastatic to the lung. 16 On the basis of microarray and functional genomics, a number of genes have been identified that are involved in the ability of these cells to form lung metastasis, the so-called lung metastasis signature. 16 We have shown that inhibition of the Ras-ERK pathway by either treatment of UO126 or knockdown of K-Ras decreases the expression level of lung metastasis signatures, as measured by RT-PCR analysis, including MMP1, ANGPTL4, CXCL1, EREG, TNC (tensacin-C) and PTGS2 (COX-2). Furthermore, previous studies demonstrated that these genes are functionally important because silencing their expression decreased the ability of LM2 cells to form lung metastasis. 16, 20, 21 Interestingly, our data are consistent with previous studies, which revealed that the Ras-ERK pathway drives the expression of several genes identified as lung metastasis signatures, including TNC, 31 MMP1 32 and EREG.
33
Further studies will be required to determine whether expression of the full cohort of lung metastasis genes previously identified are dependent on the Ras-ERK pathway. Our studies also suggest that drugs that target the Ras-ERK pathway might be suitable to prevent lung metastasis. In this regard, it is interesting to note that reducing the level of phosphorylated ERK to levels comparable to parental cells following siRNA treatment against K-Ras was sufficient to reduce the levels of lung metastasis signature genes to parental cells. Targeting the ERK pathway may provide a therapeutic strategy for metastasis.
Cross talk between the Ras-ERK and Ras-PI3K pathway drives the motility of LM2 cells Although inhibition of the Ras-ERK pathway in LM2 resulted in the formation of stress fibers and focal adhesions, there was no significant reduction in cell motility using wound healing and Boyden chamber assays ( Figure 5 ). Interestingly, we found that inhibition of the Ras-ERK pathway resulted in enhanced activation of the PI3K-AKT pathway. Recently, it was reported that inhibition of the Ras-ERK pathway impacts activation of PI3K/AKT. [24] [25] [26] Although the PI3K pathway is a critical target downstream of Ras in many cancer cells, both parental and LM2, did not have relatively high levels of phosphorylated AKT (Figure 2a ). This is in agreement with previous studies that reported that MDA-MB-231 cells have almost undetectable levels of phosphorylated AKT. 34 Thus, although these cells contain a mutant K-Ras, there is a weak activation of PI3K/AKT signaling. However, upon inhibition of the ERK pathway, PI3K/AKT pathway activation was detected ( Figures  6a and b) . This led us to examine whether the PI3K pathway might have a role in the motility of LM2 cells. Inhibition of the PI3K pathway did not significantly reduce the motility of LM2 cells. However, combination treatment with PI3K and MEK inhibitors significantly reduced wound healing motility (Figure 6d ). These data demonstrate that activation of the PI3K-AKT pathway drives the motility of LM2 when the Ras-ERK pathway is downregulated. Taken together, our data indicate that both PI3K and ERK signaling pathways contribute to cell motility. We propose the model shown in Figure 7 . The Ras-ERK pathway is responsible for disruption of stress fiber and focal adhesion formation. When the Ras-ERK pathway is inhibited following either treatment with the MEK inhibitor, UO126, or knockdown of K-Ras, actin cytoskeleton organization is restored and the expression level of lung metastasis signatures is reduced. However, activation of the PI3K pathway in response to inhibition of the Ras-ERK pathway contributes to the motility of LM2.
These studies provide mechanistic insights into the role and cross talk of the Ras-ERK and PI3K signaling pathways in actin organization, cell motility and expression of genes associated with the lung metastasis signature. The mechanism by which downregulation of the Ras-ERK pathway results in activation of the PI3K-AKT pathway and sustained cell motility remains to be established. Elucidation of the nature of the interaction between the cytoskeleton and oncogenic signaling pathways could provide new insights into therapeutic intervention in the metastasis process, including cell motility and expression of genes associated with metastasis signatures.
MATERIALS AND METHODS
Antibodies, reagents and chemicals Cells and cell culture MDA-MB-231 parental and LM2 cells and BrM2 cells were a generous gift from Dr Joan Massague. These cell lines were cultured in Dulbecco's modified Eagle's medium high glucose (Welgene, Daegu, South Korea) supplemented with 10% fetal bovine serum (JR Scientific, Woodland, CA, USA), 100 U/ml penicillin and 100 mg/ml streptomycin with L-glutamine (Welgene). All cells were cultured at 37 1C in a humidified CO 2 incubator at 5%, as suggested in previous studies. 16 
Microscopy and immunofluorescence
Cells were seeded on top of a glass coverslip in six-well plates. At indicated time periods, cells were fixed with 4% formaldehyde (Sigma-Aldrich) for 15 min. Triton X-100 (0.1%) was used to permeabilize cells. Cells plated onto the glass coverslip were incubated with indicated primary antibodies for 30-45 min, followed by incubation of a mixture of secondary antibody and phalloidin under the parafilm. Fluorescence microscopy observer Z1 (Zeiss, Jena, Germany) with Apotome2 (Zeiss) was used for observation of cell morphology. Morphology of cells was captured with the analyzing software, Axiovision 4.8 (Zeiss).
Wound healing motility and invasion assays Cells were plated in six-well plates and grown until 80% confluent. Subsequently, cells were treated with 25 mM UO126 or the same volume of dimethyl sulfoxide (DMSO) before wounding. After 48 h of incubation, wounds were created by scraping with 200-ml plastic tips across the cell monolayer. The wound area was marked with dots using a marker pen. Immediately after scraping the monolayer of cells, the cell culture medium was changed with medium containing indicated pharmacological inhibitors. A phase-contrast microscope, Eclipse TS100 (Nikon, Tokyo, Japan) was used for capturing the image during the time course (0-40 h). All experiments were repeated at least three times.
Boyden chamber migration assay
For more quantitative analysis of motility, we performed the modified Boyden chamber migration assay with or without extracellular matrix of Matrigel-coated membrane. Boyden chamber inserts of 8-mm pore size, which was suitable for epithelial cell migration, were purchased from BD Transduction Laboratories (Lexington, KY, USA). Six hundred microliters of conventional cell culture medium was used as an attractant at the bottom of 24-well plates. To reduce cell damage, cells were collected using HyQtase Thermo Fisher Scientific (Waltham, MA, USA). One hundred microliters of cells were added in indicated drug concentrations to each well (5 Â 10 4 cells), and then loaded onto the upper wells of the Boyden chamber and finally incubated for 7 h in a humidified 5% CO 2 incubator. After 7 h, the cells in the upper wells were removed using a cotton swab, and cells in the lower wells were fixed with 4% formaldehyde and permeabilized by 0.1% Triton X-100. 4',6-Diamidino-2-phenylindole (1:5000) was used to count the number of cells by a fluorescence microscope with Axiovision 4.8 and package analysis program (Zeiss).
siRNA knockdown Cells were seeded into six-well plates at 30-50% confluence of LM2. After 24 h of plating, LM2 cells were transfected with siRNA against K-Ras or ERK1/2 or negative control siRNA (Bioneer, Daejeon, South Korea) using Lipofectamine RNAi Max (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocols. Transfected cells were incubated for an additional 96 h at 37 1C in a humidified 5% CO 2 incubator as indicated earlier.
Transient transfection
MDA-MB-231 parental cells that were plated onto glass coverslips at 70-80% confluence were transiently transfected with hemagglutinintagged K-RasV12 (constitutively active form) using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Transfection was carried out for 6 h in Dulbecco's modified Eagle's medium high glucose; the optimal DNA:Lipofectamine 2000 ratio was 2 mg:4 ml. After transient transfection with hemagglutinin-tagged K-RasV12, MDA-MB-231 parental cells were cultured with 10% FBS and L-glutamine supplemented with Dulbecco's modified Eagle's medium high glucose. After 24 h, transiently transfected MDA-MB-231 parental cells were treated with UO126 at 25 mM or the same volume of DMSO for an additional 48 h, respectively.
RT-PCR analysis
Total RNA from cells was extracted using a RiboEx (GeneAll, Seoul, South Korea) and a Qiagen RNA Isolation Kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instruction. The total RNA concentration was measured using a Nanodrop spectrometer (Thermo Fisher Scientific). The generation of first-strand cDNA from total RNA and amplification of this cDNA strand were reacted together using Primer Script one-step RT-PCR Kit Ver. 2 (Takara, Otsu, Japan) and PCR machine (Bio-Rad, Richmond, CA, USA), according to the manufacturer's instructions. Differently expressed mRNA was separated by 1.2% agarose gel electrophoresis. The following specific primer sequences were used: MMP1 fwd 
Western blotting
Whole-cell extracts were prepared by lysing cells in lamelli 2 Â sample buffer containing a cocktail of phosphatase inhibitor, phosSTOP (Roche, Basel, Switzerland) and protease inhibitors. The total lysate of proteins was separated by 6-12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Proteins were transferred onto a nitrocellulose membrane and blocked with 5% powdered skim milk in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 0.01% Tween). The membrane was then incubated with indicated primary antibodies diluted into 5% bovine serum albumin in TBST. After primary antibody incubation, membranes were incubated with horse radish peroxidase-conjugated anti-mouse or -rabbit immunoglobulin G secondary antibodies diluted into 5% skim milk in TBST for 1 h. Between each steps, membranes were washed with TBST extensively more than three times for 5 min. Proteins were visualized with enhanced chemiluminescence substrate (Thermo Fisher Scientific). Both Chemi-doc MP (BioRad, Richmond, CA, USA) and convential X-ray film were used to capture images. a-Tubulin expression was evaluated as a protein loading control. Protein expression was analyzed by densitometry analysis program using the ImageJ Software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
The significance of the experimental results was determined by the Student's t-test with Microsoft Excel program.
